Elanco Animal Health Incorporated

NYSE:ELAN 株式レポート

時価総額:US$6.8b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Elanco Animal Health 過去の業績

過去 基準チェック /06

Elanco Animal Healthの収益は年間平均-44.7%の割合で減少していますが、 Pharmaceuticals業界の収益は年間 減少しています。収益は年間0.2% 9%割合で 増加しています。

主要情報

-44.7%

収益成長率

-43.4%

EPS成長率

Pharmaceuticals 業界の成長6.0%
収益成長率9.0%
株主資本利益率-21.1%
ネット・マージン-27.9%
前回の決算情報30 Jun 2024

最近の業績更新

Recent updates

Here's Why Elanco Animal Health (NYSE:ELAN) Has A Meaningful Debt Burden

Sep 22
Here's Why Elanco Animal Health (NYSE:ELAN) Has A Meaningful Debt Burden

Elanco Animal Health Incorporated (NYSE:ELAN) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Sep 01
Elanco Animal Health Incorporated (NYSE:ELAN) Surges 25% Yet Its Low P/S Is No Reason For Excitement

Elanco Animal Health: Positioned For Success

Aug 16

Investors Don't See Light At End Of Elanco Animal Health Incorporated's (NYSE:ELAN) Tunnel And Push Stock Down 27%

Jul 11
Investors Don't See Light At End Of Elanco Animal Health Incorporated's (NYSE:ELAN) Tunnel And Push Stock Down 27%

Elanco Animal Health: Pipeline Concerns Appear Overblown

Jun 30

Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet

Jun 06
Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet

Elanco Animal Health: At Least Fully Valued After Rally

Jun 05

Benign Growth For Elanco Animal Health Incorporated (NYSE:ELAN) Underpins Its Share Price

Apr 22
Benign Growth For Elanco Animal Health Incorporated (NYSE:ELAN) Underpins Its Share Price

Elanco Animal Health (NYSE:ELAN) Seems To Be Using A Lot Of Debt

Feb 24
Elanco Animal Health (NYSE:ELAN) Seems To Be Using A Lot Of Debt

Elanco Animal Health: A Solid Sale Addresses Leverage

Feb 09

Elanco Animal Health Incorporated (NYSE:ELAN) Looks Inexpensive But Perhaps Not Attractive Enough

Jan 01
Elanco Animal Health Incorporated (NYSE:ELAN) Looks Inexpensive But Perhaps Not Attractive Enough

Elanco Animal Health: Turning More Healthy

Dec 21

Is Elanco Animal Health (NYSE:ELAN) A Risky Investment?

Nov 09
Is Elanco Animal Health (NYSE:ELAN) A Risky Investment?

Elanco Animal Health: Signs Of Stabilization, Amidst Still A Big Debt Pile

Oct 05

Here's Why Elanco Animal Health (NYSE:ELAN) Is Weighed Down By Its Debt Load

Aug 02
Here's Why Elanco Animal Health (NYSE:ELAN) Is Weighed Down By Its Debt Load

Elanco Animal Health: Seems Like A Decent Bet Right Now

Jul 25

Elanco Animal Health: Robust Results Overshadowed By Persisting Challenges

Jul 14

There's No Escaping Elanco Animal Health Incorporated's (NYSE:ELAN) Muted Revenues

Jun 09
There's No Escaping Elanco Animal Health Incorporated's (NYSE:ELAN) Muted Revenues

Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet

Feb 22
Elanco Animal Health (NYSE:ELAN) Has A Somewhat Strained Balance Sheet

Elanco Q4 2022 Earnings Preview

Feb 20

Elanco's Tangible Equity Units: Living With The Worst Case

Dec 13

We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt

Nov 08
We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt

Elanco Q3 2022 Earnings Preview

Nov 07

Elanco Animal Health: This 'Sick Dog' Should Recover

Oct 19

Elanco adds 9% as activist investor Sachem Head raises stake

Sep 09

Elanco Animal Health hits another 52-week low. What's going on with the company?

Aug 23

Elanco Animal Health hits 52-week low; down 33% YTD

Aug 16

Elanco Q2 2022 Earnings Preview

Aug 05

We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt

Jul 25
We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt

収支内訳

Elanco Animal Health の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。


収益と収入の歴史

NYSE:ELAN 収益、費用、利益 ( )USD Millions
日付収益収益G+A経費研究開発費
30 Jun 244,492-1,2551,291341
31 Mar 244,365-1,3021,290333
31 Dec 234,417-1,2311,280327
30 Sep 234,367-1,1441,289328
30 Jun 234,324-1131,273320
31 Mar 234,442-261,263321
31 Dec 224,411-781,259321
30 Sep 224,538-1321,290333
30 Jun 224,644-1711,334349
31 Mar 224,748-3711,372361
31 Dec 214,764-4831,395369
30 Sep 214,791-6981,431390
30 Jun 214,550-7291,373384
31 Mar 213,857-5721,153349
31 Dec 203,271-574988329
30 Sep 202,921-246810281
30 Jun 202,802-101719263
31 Mar 202,998-13759273
31 Dec 193,07168757270
30 Sep 193,08394759264
30 Jun 193,073144746253
31 Mar 193,06245736246
31 Dec 183,06787735247
30 Sep 183,022-91747248
30 Jun 182,958-172763250
31 Mar 182,906-174766253
31 Dec 172,889-311780252
31 Dec 162,914-48785266
31 Dec 152,909-211916291

質の高い収益: ELANは現在利益が出ていません。

利益率の向上: ELANは現在利益が出ていません。


フリー・キャッシュフローと収益の比較


過去の収益成長分析

収益動向: ELANは利益が出ておらず、過去 5 年間で損失は年間45.4%の割合で増加しています。

成長の加速: ELANの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。

収益対業界: ELANは利益が出ていないため、過去 1 年間の収益成長をPharmaceuticals業界 ( 13% ) と比較することは困難です。


株主資本利益率

高いROE: ELANは現在利益が出ていないため、自己資本利益率 ( -21.12% ) はマイナスです。


総資産利益率


使用総資本利益率


過去の好業績企業の発掘